Nanogel-based antigen-delivery system for nasal vaccines

Biotechnology and Genetic Engineering Reviews

Volumn 29, Issue 1, 2013, Pages 61-72

  Yukia, Yoshikazu ^a   Nochi, Tomonori ^a   Kong, Il Gyu ^a   Takahashi, Haruko ^b   Sawada, Shin Ichi ^b   Akiyoshi, Kazunari ^b   Kiyono, Hiroshi ^a  

^a THE UNIVERSITY OF TOKYO   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Antigen delivery; Chaperone; Nanogel; Nanotechnology; Nasal vaccine

Indexed keywords

ANTIGENS; DISEASES; HISTOLOGY; NANOSTRUCTURED MATERIALS; TISSUE; VACCINES;

ANTIGEN DELIVERY; ANTIGEN DELIVERY SYSTEM; CHAPERON; IMMUNIZATION ROUTES; INFECTIOUS DISEASE; LYMPHOID TISSUE; NANOGELS; NASAL VACCINATION; NASAL VACCINE; SINGLE LAYER;

NANOGELS;

ADJUVANT; ANTIGEN; CHAPERONE; VACCINE; MACROGOL DERIVATIVE; NANOGEL; POLYETHYLENEIMINE;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG SAFETY; GEL; HUMAN; IMMUNE SYSTEM; IMMUNIZATION; IMMUNOLOGY; INFECTION; MOLECULAR INTERACTION; NANOGEL; NANOTECHNOLOGY; NONHUMAN; PROTEIN FUNCTION; CHEMISTRY; GENE TRANSFER; INTRANASAL DRUG ADMINISTRATION;

ADMINISTRATION, INTRANASAL; ANTIGENS; GENE TRANSFER TECHNIQUES; HUMANS; MOLECULAR CHAPERONES; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE; VACCINES;

EID: 84881149172     PISSN: 02648725     EISSN: None     Source Type: Journal    
DOI: 10.1080/02648725.2013.801226     Document Type: Article

References (39)

1. Ayame, H., Morimoto, N., & Akiyoshi, K. (2008). Self-assembled cationic nanogels for intracellular protein delivery. Bioconjugate Chemistry, 19, 882-890. (Pubitemid 351614544)
2. Belshe, R., Lee, M. S., Walker, R. E., Stoddard, J., & Mendelman, P. M. (2004). Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine. Expert Review of Vaccines, 3, 643-654. (Pubitemid 39576751)
3. Briles, D. E., Hollingshead, S. K., Paton, J. C., Ades, E. W., Novak, L., van Ginkel, F. W., & Benjamin, W. H.Jr (2003). Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae. Journal of Infectious Diseases, 188, 339-348. (Pubitemid 36966099)
4. Campbell, J. J., Brightling, C. E., Symon, F. A., Qin, S., Murphy, K. E., Hodge, M., Andrew, D. P., Wu, L., Butcher, E. C., & Wardlaw, A. J. (2001). Expression of chemokine receptors by lung T cells from normal and asthmatic subjects. Journal of Immunology, 166, 2842-2848. (Pubitemid 32173526)
5. Czerkinsky, C., Anjuere, F., McGhee, J. R., George-Chandy, A., Holmgren, J., Kieny, M. P., Sun, J. B. (1999). Mucosal immunity and tolerance: Relevance to vaccine development. Immunological Reviews, 170, 197-222. (Pubitemid 29490755)
6. Girard, M. P., Cherian, T., Pervikov, Y., & Kieny, M. P. (2005). A review of vaccine research and development: Human acute respiratory infections. Vaccine, 23, 5708-5724. (Pubitemid 41668877)
7. Hartl, F. U. (1996). Molecular chaperones in cellular protein folding. Nature, 381, 571-579.
8. Holmgren, J., & Czerkinsky, C. (2005). Mucosal immunity and vaccines. Nature Medicine, 11, S45-53. (Pubitemid 40562303)
9. Ikuta, Y., Katayama, N., Wang, L., Okugawa, T., Takahashi, Y., Schmitt, M., Shiku, H. (2002). Presentation of a major histocompatibility complex class 1-binding peptide by monocyte-derived dendritic cells incorporating hydrophobized polysaccharide-truncated HER2 protein complex: Implications for a polyvalent immuno-cell therapy. Blood, 99, 3717-3724. (Pubitemid 34534543)
10. Iwasaki, A. (2007). Mucosal dendritic cells. Annual Review of Immunology, 25, 381-418. (Pubitemid 46697912)
11. Iwata, M., Hirakiyama, A., Eshima, Y., Kagechika, H., Kato, C., & Song, S. Y. (2004). Retinoic acid imprints gut-homing specificity on T cells. Immunity, 21, 527-538. (Pubitemid 39370508)
12. Kabanov, A. V., & Vinogradov, S. V. (2009). Nanogels as pharmaceutical carriers: Finite networks of infinite capabilities. Angewandte Chemie International Edition (English), 48, 5418-5429.
13. Kaetzel, C. S. (2005). The polymeric immunoglobulin receptor: Bridging innate and adaptive immune responses at mucosal surfaces. Immunological Reviews, 206, 83-99. (Pubitemid 41105164)
14. Kim, D. Y., Sato, A., Fukuyama, S., Sagara, H., Nagatake, T., Kong, I. G., Kiyono, H. (2011). The airway antigen sampling system: Respiratory M cells as an alternative gateway for inhaled antigens. Journal of Immunology, 186, 4253-4262.
15. Kiyono, H., & Fukuyama, S. (2004). NALT-versus Peyer's-patch-mediated mucosal immunity. Nature Reviews. Immunology, 4, 699-710. (Pubitemid 39223076)
16. Kong, I., Sato, A., Yuki, Y., Nochi, T., Takahashi, H., Sawada, S., Kiyono, H. (2013). Nanogel-based PspA intranasal vaccine prevents invasive disease and nasal colonization by Pneumococcus. Infection and Immunity, 81, 1625-1634.
17. Kunisawa, J., Fukuyama, S., & Kiyono, H. (2005). Mucosa-associated lymphoid tissues in the aerodigestive tract: Their shared and divergent traits and their importance to the orchestration of the mucosal immune system. Current Molecular Medicine, 5, 557-572. (Pubitemid 41236556)
18. Leader, B., Baca, Q. J., & Golan, D. E. (2008). Protein therapeutics: A summary and pharmacological classification. Nature Reviews. Drug Discovery, 7, 21-39.
19. McGhee, J. R., Fujihashi, K., Beagley, K. W., & Kiyono, H. (1991). Role of interleukin-6 in human and mouse mucosal IgA plasma cell responses. Immunologic Research, 10, 418-422.
20. Mora, J. R., Iwata, M., Eksteen, B., Song, S. Y., Junt, T., Senman, B., von Andrian, U. H. (2006). Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science, 314, 1157-1160. (Pubitemid 44789048)
21. Mutsch, M., Zhou, W., Rhodes, P., Bopp, M., Chen, R. T., Linder, T., Steffen, R. (2004). Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. New England Journal of Medicine, 350, 896-903. (Pubitemid 38252537)
22. Neutra, M. R., Frey, A., & Kraehenbuhl, J. P. (1996). Epithelial M cells: Gateways for mucosal infection and immunization. Cell, 86, 345-348. (Pubitemid 26272074)
23. Neutra, M. R., & Kozlowski, P. A. (2006). Mucosal vaccines: The promise and the challenge. Nature Reviews. Immunology, 6, 148-158. (Pubitemid 43361590)
24. Nochi, T., Yuki, Y., Takahashi, H., Sawada, S., Mejima, M., Kohda, T., Kiyono, H. (2010). Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines. Nature Materials, 9, 572-578.
25. Nomura, Y., Ikeda, M., Yamaguchi, N., Aoyama, Y., & Akiyoshi, K. (2003). Protein refolding assisted by self-assembled nanogels as novel artificial molecular chaperone. FEBS Letters, 553, 271-276. (Pubitemid 37315616)
26. Park, J. B., & Simpson, L. L. (2003). Inhalational poisoning by botulinum toxin and inhalation vaccination with its heavy-chain component. Infection and Immunity, 71, 1147-1154. (Pubitemid 36254295)
27. Rescigno, M., Urbano, M., Valzasina, B., Francolini, M., Rotta, G., Bonasio, R., Ricciardi-Castagnoli, P. (2001). Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nature Immunology, 2, 361-367. (Pubitemid 33706348)
28. Ryan, E. J., McNeela, E., Murphy, G. A., Stewart, H., O'Hagan, D., Pizza, M., Mills, K. H. (1999). Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: Differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells. Infection and Immunity, 67, 6270-6280.
29. Sasaki, Y., & Akiyoshi, K. (2010a). Development of an artificial chaperone system based on cyclodextrin. Current Pharmaceutical Biotechnology, 11, 300-305.
30. Sasaki, Y., & Akiyoshi, K. (2010b). Nanogel engineering for new nanobiomaterials: From chaperoning engineering to biomedical applications. Chemical Record, 10, 366-376.
31. Taguchi, H., Ueno, T., Tadakuma, H., Yoshida, M., & Funatsu, T. (2001). Single-molecule observation of protein-protein interactions in the chaperonin system. Nature Biotechnology, 19, 861-865. (Pubitemid 32816757)
32. Tsuji, K., Hamada, T., Uenaka, A., Wada, H., Sato, E., Isobe, M., Iwatsuki, K. (2008). Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patient. Cancer Immunology, Immunotherapy: CII, 57, 1429-1437.
33. van Ginkel, F. W., Jackson, R. J., Yuki, Y., & McGhee, J. R. (2000). Cutting edge: The mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues. Journal of Immunology, 165, 4778-4782.
34. Watanabe, K., Tsuchiya, Y., Kawaguchi, Y., Sawada, S., Ayame, H., Akiyoshi, K., & Tsubata, T. (2011). The use of cationic nanogels to deliver proteins to myeloma cells and primary T lymphocytes that poorly express heparan sulfate. Biomaterials, 32, 5900-5905.
35. Yamamoto, M., Briles, D. E., Yamamoto, S., Ohmura, M., Kiyono, H., & McGhee, J. R. (1998). A nontoxic adjuvant for mucosal immunity to pneumococcal surface protein A. Journal of Immunology, 161, 4115-4121. (Pubitemid 28468991)
36. Yamamoto, S., Kiyono, H., Yamamoto, M., Imaoka, K., Fujihashi, K., Van Ginkel, F. W., McGhee, J. R. (1997). A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity. Proceedings of the National Academy of Sciences of the United States of America, 94, 5267-5272. (Pubitemid 27214772)
37. Yuki, Y., & Kiyono, H. (2003). New generation of mucosal adjuvants for the induction of protective immunity. Reviews in Medical Virology, 13, 293-310. (Pubitemid 37082192)
38. Yuki, Y., & Kiyono, H. (2009). Mucosal vaccines: Novel advances in technology and delivery. Expert Review of Vaccines, 8, 1083-1097.
39. Yuki, Y., Nochi, T., Harada, N., Katakai, Y., Shibata, H., Mejima, M., Kiyono, H. (2010). In vivo molecular imaging analysis of a nasal vaccine that induces protective immunity against botulism in nonhuman primates. Journal of Immunology, 185, 5436-5443.